Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2019

View Archived Issues

Corona-mediated brain targeting using short peptides for association of exchangeable apolipoproteins

Claudin-5 is a key mediator of retinal pigment epithelium pathology regulated by the circadian clock

Palbociclib prevents chemo hair loss

Inflammation stress induces red blood cell formation

Omeros presents promising phase I results for PDE7 inhibitor OMS-182399 for addiction

Enrollment ongoing in phase I study of EBV TCR-T cell therapy

Otonomy announces initiation of phase I/II study of OTO-413

Preliminary data announced from ongoing phase II study of fosmanogepix in candidemia

Treatment with luseogliflozin reverses cognitive impairments in elderly diabetes

Preliminary first-in-human data for ATA-188 support continuation of study

AMG-510 shows favorable safety profile, early promising antitumor activity in patients with NSCLC

IFN-alpha kinoid shows promise as a vaccine against type 1 diabetes in a NOD murine model

Gulp and scarf: senescent breast cancer cells eat their neighbors

Artax Biopharma presents new immunomodulators

Gilead Sciences divulges new antivirals for HBV infection

Ferro Therapeutics identifies PHGPx inhibitors

Samumed identifies new DYRK1A and/or GSK-3beta and IL-6 production inhibitors

Vitamin C-coupled compounds for cancer described in Gudui Biopharma Technology patent

FDA approves Erleada for metastatic castration-sensitive prostate cancer

Novel oxyntomodulin analogue OXM-001 reduces body weight and improves glucose tolerance

Keytruda plus Lenvima gains FDA approval for advanced endometrial carcinoma

Saniona reports phase IIa data analysis on Tesomet in adolescents with Prader-Willi syndrome

FDA clears IND for Ceraxa in AML

Antisense Therapeutics reports preliminary phase II data on ATL-1102 in Duchenne muscular dystrophy

Durect completes phase IIa trial of DUR-928 in alcoholic hepatitis

Ra's zilucoplan selected for evaluation in ALS platform trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...